ELOX Eloxx Pharmaceuticals Inc.

Eloxx Pharmaceuticals Inc is a United States-based clinical-stage pharmaceutical company. It is focused on building and developing a portfolio of therapeutics for the treatment of cancer and immunological diseases.

As of 09/16/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/18/2014
Outstanding shares:  86,202,772
Average volume:  795,112
Market cap:   $137,062,407
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    29014R103
ISIN:        US29014R1032
Sedol:      BFFWHH1
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.71
PS ratio:   0.00
Return on equity:   -211.47%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy